Multimodal neuroimaging: Potential biomarkers for response to antiepileptic drugs?

Epilepsia

Volumn 54, Issue , 2013, Pages 67-70

  Coan, Ana C ^a   Cendes, Fernando ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Antiepileptic drugs; Biomarkers; Epileptogenic lesions; Functional imaging; Magnetic resonance imaging; Neuronal damage; Outcome; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; BIOLOGICAL MARKER;

ANTICONVULSANT THERAPY; ARTICLE; EPILEPTIC FOCUS; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; MULTIMODAL IMAGING; NEUROIMAGING; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; SEIZURE; TREATMENT RESPONSE; ANIMAL; EPILEPSY; METABOLISM; METHODOLOGY; REVIEW; TREATMENT OUTCOME;

ANIMALS; ANTICONVULSANTS; BIOLOGICAL MARKERS; EPILEPSY; HUMANS; NEUROIMAGING; TREATMENT OUTCOME;

EID: 84880457839     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12188     Document Type: Article

References (24)

1. Bilevicius E, Yasuda CL, Silva MS, Guerreiro CA, Lopes-Cendes I, Cendes F. (2010) Antiepileptic drug response in temporal lobe epilepsy: A clinical and MRI morphometry study. Neurology 75:1695-1701.
2. Borsook D, Becerra L, Hargreaves R. (2006) A role for fMRI in optimizing CNS drug development. Nat Rev Drug Discov 5:411-425.
3. Brodie MJ, Barry SJ, Bamagous GA, Norrie JD, Kwan P. (2012) Patterns of treatment response in newly diagnosed epilepsy. Neurology 78:1548-1554.
4. Butler T, Ichise M, Teich AF, Gerard E, Osborne J, French J, Devinsky O, Kuzniecky R, Gilliam F, Pervez F, Provenzano F, Goldsmith S, Vallabhajosula S, Stern E, Silbersweig D. (2013) Imaging inflammation in a patient with epilepsy due to focal cortical dysplasia. J Neuroimaging 23:129-131.
5. Campos BA, Yasuda CL, Castellano G, Bilevicius E, Li LM, Cendes F. (2010) Proton MRS may predict AED response in patients with TLE. Epilepsia 51:783-788.
6. Cardoso TA, Coan AC, Kobayashi E, Guerreiro CA, Li LM, Cendes F. (2006) Hippocampal abnormalities and seizure recurrence after antiepileptic drug withdrawal. Neurology 67:134-136.
7. Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT. (2004) Medical genetics: A marker for Stevens-Johnson syndrome. Nature 428:486.
8. Coan AC, Appenzeller S, Bonilha L, Li LM, Cendes F. (2009) Seizure frequency and lateralization affect progression of atrophy in temporal lobe epilepsy. Neurology 73:834-842.
9. Coan AC, Beltramini GC, Campos BM, Covolan R, Cendes F. (2012) EEG-fMRI haemodynamic responses of patients with non-lesional mesial temporal lobe epilepsy (MTLE). Neurology 78:P03.113. [Abstract.]
10. Conz L, Morita ME, Coan AC, Kobayashi E, Yasuda CL, Pereira AR, Lopes-Cendes I, Cendes F. (2011) Longitudinal MRI volumetric evaluation in patients with familial mesial temporal lobe epilepsy. Front Neurol 2:5.
11. de Tisi J, Bell GS, Peacock JL, McEvoy AW, Harkness WF, Sander JW, Duncan JS. (2011) The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: A cohort study. Lancet 378:1388-1395.
12. Duffy BA, Choy M, Riegler J, Wells JA, Anthony DC, Scott RC, Lythgoe MF. (2012) Imaging seizure-induced inflammation using an antibody targeted iron oxide contrast agent. Neuroimage 60: 1149-1155.
13. Fedi M, Berkovic SF, Marini C, Mulligan R, Tochon-Danguy H, Reutens DC. (2006) A GABAA receptor mutation causing generalized epilepsy reduces benzodiazepine receptor binding. Neuroimage 32:995-1000.
14. Filibian M, Frasca A, Maggioni D, Micotti E, Vezzani A, Ravizza T. (2012) In vivo imaging of glia activation using 1H-magnetic resonance spectroscopy to detect putative biomarkers of tissue epileptogenicity. Epilepsia 53:1907-1916.
15. French J, Chen Y, Fan X, Hoock T, Martin M, Paskavitz J, Wright C, Vezzani A. (2011) VX-765, a novel, investigational antiinflammatory agent which inhibits IL-1b production: Proof-ofconcept trial for refractory partial onset seizures. American Epilepsy Society Annual Meeting. Epilepsy Curr 12(Suppl. 1):275. [Abstract No 3.187.]
16. Hesdorffer DC, Tomson T, Benn E, Sander JW, Nilsson L, Langan Y, Walczak TS, Beghi E, Brodie MJ, Hauser A, ILAE Commission on Epidemiology, Subcommission on Mortality. (2011) Combined analysis of risk factors for SUDEP. Epilepsia 52:1150-1159.
17. Jones T, Rabiner EA, PET Research Advisory Company. (2012) The development, past achievements, and future directions of brain PET. J Cereb Blood Flow Metab 32:1426-1454.
18. Kwan P, Brodie MJ. (2000) Early identification of refractory epilepsy. N Engl J Med 342:314-319.
19. McCormack M, Alfirevic A, Bourgeois S, Farrell JJ, Kasperavičiūtė D, Carrington M, Sills GJ, Marson T, Jia X, de Bakker PI, Chinthapalli K, Molokhia M, Johnson MR, O’Connor GD, Chaila E, Alhusaini S, Shianna KV, Radtke RA, Heinzen EL, Walley N, Pandolfo M, Pichler W, Park BK, Depondt C, Sisodiya SM, Goldstein DB, Deloukas P, Delanty N, Cavalleri GL, Pirmohamed M. (2011) HLAA* 3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med 364:1134-1143.
20. Morita ME, Yasuda CL, Betting LE, Pacagnella D, Conz L, Barbosa PH, Maurer-Morelli CV, Costa ALF, Kobayashi E, Lopes-Cendes I, Cendes F. (2012) MRI and EEG as long-term seizure outcome predictors in familial mesial temporal lobe epilepsy. Neurology 79:2349-2354.
21. Silva MS, Bilevicius E, Santos RO, Secolin R, Maurer-Morelli CV, Cendes F, Lopes Cendes I. (2010) Polymorphisms in drugtransporter genes are significantly associated with response to antiepileptic drugs in mesial temporal lobe epilepsy. Neurology 74:303.
22. Thornton R, Laufs H, Rodionov R, et al. (2010) EEG correlated functional MRI and postoperative outcome in focal epilepsy. J Neurol Neurosurg Psychiatry 81:922-927.
23. Thornton R, Vulliemoz S, Rodionov R, et al. (2011) Epileptic networks in focal cortical dysplasia revealed using electroencephalographyfunctional magnetic resonance imaging. Ann Neurol 70:822-837.
24. Yasuda CL, Morita ME, Alessio A, Pereira AR, Balthazar ML, Safflde AV, Costa AL, Costa AL, Cardoso TA, Betting LE, Guerreiro CA, Damasceno BP, Lopes-Cendes I, Tedeschi H, de Oliveira E, Cendes F. (2010) Relationship between environmental factors and gray matter atrophy in refractory MTLE. Neurology 74:1062-1068.